Central nervous system and Cryptococcus neoformans.

作者: VeronicaA Gaona-Flores

DOI: 10.4103/1947-2714.117321

关键词:

摘要: Cryptococcus neoformans continues to be an important cause of morbidity and mortality, is the most common central nervous system (CNS) mycosis in immunocompromised patients, particular those with AIDS. C. has also increased transplant patients,[1,2,3,4] a systemic mycosis. The incidence infection due varies among continents. C. form yeast biochemical, antigenic, epidemiological differences. There are two known varieties. Most infections var. grubii lesser number gattii (Africa, Australia, Canada, Latin America). Clinical presentations depend on characteristics immunological competency patients. In general, it fungal its origin as inhalation neoformans, initially affecting lungs. Therefore, CNS manifestations result dissemination this fungus from lung.[5] The polysaccharide capsule potent virulence factor, which allows evade immune system. Laboratory diagnosis accomplished either by ELISA or latex agglutination test, visualization upon direct examination fresh cerebrospinal fluid (CSF), China ink (India staining nigrosine for identification 4-20 mm diameter). With negative stain, image center will possible. When burden high, pseudomycelium may observed time. On other occasions practical centrifuge CSF at 3,000 rpm Χ 10 min. sediment useful microscopic study cultures. Another accessible agglutination, identifies A, B, C, D serotypes that constitute neoformans/C. complex. Clinical correlation suspicion important. As all laboratory tests, there false negatives positives, thereby importance obtaining culture, yeasts neoformans. Genotypic proposed genotyping working group selected multilocus sequence typing (MLST), structural genes.[6] Treatment been established,[7] however, we must pay close attention not only treatment, but cryptococcal reconstitution inflammatory syndrome (IRIS) present itself clinical deterioration new recurrent presentation disease after initiation antiretroviral therapy (ART), despite microbiological evidence effective antifungal treatment.[8,9]

参考文章(9)
Thomas G. Mitchell, Anastasia P. Litvintseva, Typing Species of Cryptococcus and Epidemiology of Cryptococcosis Springer, Berlin, Heidelberg. pp. 167- 190 ,(2010) , 10.1007/978-3-642-03150-2_8
G. Wu, R.A. Vilchez, B. Eidelman, J. Fung, R. Kormos, S. Kusne, Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients Transplant Infectious Disease. ,vol. 4, pp. 183- 188 ,(2002) , 10.1034/J.1399-3062.2002.T01-1-02005.X
Tihana Bicanic, Graeme Meintjes, Kevin Rebe, Anthony Williams, Angela Loyse, Robin Wood, Madeleine Hayes, Shabbar Jaffar, Thomas Harrison, Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. Journal of Acquired Immune Deficiency Syndromes. ,vol. 51, pp. 130- 134 ,(2009) , 10.1097/QAI.0B013E3181A56F2E
Elvis Temfack, MariePatrice Halle, BenjaminClet Nguenkam Tchaleu, YacoubaNjankouo Mapoure, Sinata Koulla-Shiro, HenryNamme Luma, Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Douala, Cameroon: A Cross Sectional Study North American Journal of Medical Sciences. ,vol. 5, pp. 486- 491 ,(2013) , 10.4103/1947-2714.117318
F.P. Silveira, S. Husain, E.J. Kwak, P.K. Linden, A. Marcos, R. Shapiro, P. Fontes, J.W. Marsh, M. de Vera, K. Tom, N. Thai, H.P. Tan, A. Basu, K. Soltys, D.L. Paterson, Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab Transplant Infectious Disease. ,vol. 9, pp. 22- 27 ,(2007) , 10.1111/J.1399-3062.2006.00149.X
Kerrigan M McCarthy, Juliette Morgan, Kathleen A Wannemuehler, Sara A Mirza, Susan M Gould, Ntombi Mhlongo, Portia Moeng, Bonnie R Maloba, Heather H Crewe-Brown, Mary E Brandt, Rana A Hajjeh, Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS. ,vol. 20, pp. 2199- 2206 ,(2006) , 10.1097/QAD.0B013E3280106D6A
Shaunna M. Huston, Christopher H. Mody, Cryptococcosis: an emerging respiratory mycosis. Clinics in Chest Medicine. ,vol. 30, pp. 253- 264 ,(2009) , 10.1016/J.CCM.2009.02.006
David R. Boulware, Shulamith C. Bonham, David B. Meya, Darin L. Wiesner, Gregory S. Park, Andrew Kambugu, Edward N. Janoff, Paul R. Bohjanen, Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome The Journal of Infectious Diseases. ,vol. 202, pp. 962- 970 ,(2010) , 10.1086/655785
John R. Perfect, William E. Dismukes, Francoise Dromer, David L. Goldman, John R. Graybill, Richard J. Hamill, Thomas S. Harrison, Robert A. Larsen, Olivier Lortholary, Minh-Hong Nguyen, Peter G. Pappas, William G. Powderly, Nina Singh, Jack D. Sobel, Tania C. Sorrell, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clinical Infectious Diseases. ,vol. 50, pp. 291- 322 ,(2010) , 10.1086/649858